Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiac Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05489549
What this trial is testing

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Who this might be right for
Amyloidosis, HereditaryAmyloidosis CardiacAmyloidosis, Familial+2 more
University of Texas Southwestern Medical Center 500
Not applicableLooking for participantsNCT07382128
What this trial is testing

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

Who this might be right for
HCM - Hypertrophic CardiomyopathyAnderson Fabry DiseaseCardiac Magnetic Resonance Imaging+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 250
Not applicableLooking for participantsNCT06907836
What this trial is testing

Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine

Who this might be right for
Cardiac Amyloidosis
University Hospital, Strasbourg, France 30
Not applicableLooking for participantsNCT06907186
What this trial is testing

An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Hereditary Transthyretin Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT07116473
What this trial is testing

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

Who this might be right for
Amyloidosis in Transthyretin (TTR)Amyloidosis, FamilialAmyloid Cardiomyopathy+7 more
Eidos Therapeutics, a BridgeBio company 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT07608354
What this trial is testing

Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
AstraZeneca 326
Not applicableStudy completedNCT01705626
What this trial is testing

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

Who this might be right for
Polyneuropathy, AmyloidNeuropathic PainCardiac Failure+2 more
CENTOGENE GmbH Rostock 500
Large-scale testing (Phase 3)Study completedNCT00294671
What this trial is testing

The Effect of Diflunisal on Familial Amyloidosis

Who this might be right for
Familial Amyloid PolyneuropathyFamilial Amyloidosis
Boston University 130
Large-scale testing (Phase 3)Active Not RecruitingNCT04153149
What this trial is testing

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals 655
Not applicableStudy completedNCT06018194
What this trial is testing

ELUCIDATE FFRct Study

Who this might be right for
Coronary Artery Disease
Elucid Bioimaging Inc. 439
Not applicableLooking for participantsNCT07822737
What this trial is testing

PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study

Who this might be right for
Coronary Artery DiseasePlaquePhoton-Counting Computed Tomography
Beijing Chao Yang Hospital 500
Not applicableUnknownNCT05699044
What this trial is testing

Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation

Who this might be right for
Amyloid CardiomyopathyBlock, AV
Steen Hvitfeldt Poulsen 170
Early research (Phase 1)Study completedNCT05374564
What this trial is testing

Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy

Who this might be right for
Cardiomyopathies, Primary
Yale University 12
Not applicableStudy completedNCT04421040
What this trial is testing

Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors

Who this might be right for
TTR Cardiac Amyloidosis
Mayo Clinic 24
Not applicableUnknownNCT04146415
What this trial is testing

Diagnosis of Cardiac Amyloidosis With 99mTc-PYP; Comparison Between Planar Imaging, SPECT/CT and Cardiac-dedicated CZT Camera

Who this might be right for
Cardiac Amyloidosis
Tel-Aviv Sourasky Medical Center 30
Very early researchLooking for participantsNCT06082050
What this trial is testing

Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy

Who this might be right for
Transthyroxin Amyloidosis Cardiomyopathy
Zhejiang University 7
Not applicableLooking for participantsNCT07654855
What this trial is testing

Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

Who this might be right for
Transthyretin AmyloidosisTransthyretin Amyloidosis With CardiomyopathyTransthyretin Amyloidosis With Polyneuropathy
AstraZeneca 320
Testing effectiveness (Phase 2)Study completedNCT05442047
What this trial is testing

A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S 105
Not applicableUnknownNCT05754099
What this trial is testing

Identification of Clinically Significant Markers of ATTRv in Pre-symptomatic Mutation Carriers.

Who this might be right for
Amyloidosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03536767
What this trial is testing

Open-Label Study of AG10 in Patients with Cardiomyopathy

Who this might be right for
Amyloid Cardiomyopathy
Eidos Therapeutics, a BridgeBio company 55
Next Page